HOME >> MEDICINE >> NEWS
Hormone therapy may still offer important health benefits to postmenopausal women

(SACRAMENTO, Calif.) -- Despite the highly publicized closing of the Women's Health Initiative study, the scientific community should not rule out that women may benefit from hormone therapy after menopause, say researchers at UC Davis, Duke and Harvard Universities. Their review of the scientific literature on the biology of estrogens and progestins appears in the May 28 issue of the journal Science.

"It was right to close the Women's Health Initiative trial," said Judith L. Turgeon, professor of internal medicine at UC Davis School of Medicine and senior author of the Science article. "But we should not generalize the results of this trial and overlook the real potential that other forms of hormone therapy may offer to postmenopausal women."

The Women's Health Initiative trials used the steroid formulation most frequently prescribed in the United States at the time, given to women in pill form on a daily basis. New information gleaned from basic research in the biology of ovarian hormones, however, indicates that not all estrogens and progestins are alike, nor do they behave identically in different tissues in the body.

"As our understanding of the biology of these hormones grows, the more we realize how important certain factors are -- such as formulation, dosage, whether they're given by a pill or a patch, and characteristics of women being treated," said co-author Phyllis M. Wise, dean of the division of biological sciences and distinguished professor of neurobiology, physiology and behavior at UC Davis. "More targeted therapies may yield important health benefits."

Estrogens affect many tissues in the body. During natural menopause, which occurs in women at an average age of 51 years, estrogen and progesterone secretion from the ovaries diminish. Afterwards, the risk of coronary heart disease and osteoporosis increases. Stroke and dementia are also associated with aging.

"Estrogens and progestins provi
'"/>

Contact: Carole Gan
916-734-9047
University of California, Davis - Health System
27-May-2004


Page: 1 2 3

Related medicine news :

1. Hormone therapy increases risk of urinary incontinence
2. Hormone therapy controversy raises drug safety issues
3. Endocrine Society and Hormone Foundation call for increased research
4. Hormone may offer hope for treating some behavioral disorders
5. Hormone found to protect bones
6. Hormone released by bone marrow cells may hasten recovery from brain injury
7. Hormones increase side effects, complicate treatment decision for prostate cancer patients
8. Hormones and drugs that control blood pressure also control malaria infection
9. Hormone replacement therapy reviewing the evidence
10. Hormone prompts adult stem cells to differentiate into islet cells
11. Hormone therapy study stopped due to increased breast cancer risk, lack of overall benefit

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... Odds, are scheduled to provide a unique keynote address at the 2016 ... the inspirational stories of five community college students. Their stories—of complicated family issues, ...
(Date:5/6/2016)... Milford, PA (PRWEB) , ... May 06, 2016 ... ... CoolSculpting does to reduce fat areas around the body, is the most ... The survey results just released make perfect sense to cosmetic surgeon Dr. Richard ...
(Date:5/6/2016)... ... ... Mark Black is a speaker, author, and life strategy coach who is spreading the ... help of his publisher Strategic Book Group and its subsidiary Publish on Demand Global ... a miracle: He needed a heart and double-lung transplant. From this came a life-changing transformation ...
(Date:5/6/2016)... ... May 06, 2016 , ... ... Sovaldi, which made headlines mostly for its cost despite its potential to wipe ... questions surrounding the drug—part of a class called direct-acting antivirals (DAAs)—have created fallout ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... President at CareFirst Blue Cross BlueShield and Former Principal Deputy Administrator at Centers ... - an Anthem Company; Steve Ondra, MD, Chief Medical Officer at Health Care ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 2016 In March, 2016, ... of free workshops across Africa ... for Good Distribution Practices (GDP). Good Distribution Practice ... products are consistently stored, transported and handled under suitable ... specification. Only a few years ago, there were ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Multiple Myeloma Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Multiple Myeloma epidemiology, Multiple Myeloma market valuations ...
(Date:5/4/2016)... DUBLIN , May 4, 2016 /PRNewswire/ ... the addition of the  "Global Acute Myeloid ... 2016"  report to their offering.  ... ,Global Acute Myeloid Leukemia Market and Competitive ... Acute Myeloid Leukemia pipeline products, Acute Myeloid ...
Breaking Medicine Technology:
Cached News: